HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$3.07
Day range
$3.01 - $3.14
Year range
$2.75 - $11.79
Market cap
16.69M USD
Avg Volume
12.92K
P/E ratio
2,025.97
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 3.49M | 1,514.99% |
Operating expense | 1.95M | -30.74% |
Net income | 1.78M | 178.09% |
Net profit margin | 51.04 | 104.83% |
Earnings per share | — | — |
EBITDA | 1.56M | 160.38% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.63M | -1.83% |
Total assets | 22.51M | -2.13% |
Total liabilities | 1.51M | -42.51% |
Total equity | 21.00M | — |
Shares outstanding | 5.35M | — |
Price to book | 0.78 | — |
Return on assets | 17.88% | — |
Return on capital | 18.98% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 1.78M | 178.09% |
Cash from operations | 1.70M | 184.16% |
Cash from investing | 761.06K | -72.09% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 2.46M | 252.33% |
Free cash flow | 708.96K | -100.00% |
About
Founded
1997
Headquarters
Website
Employees
16